The global injectable benzodiazepines market is anticipated to grow steadily, with a projected growth rate exceeding 2.7% in 2020. Key drivers of this growth include increasing adoption of generic injectable benzodiazepines, rising prevalence of mental disorders, and short-term demand spikes caused by the COVID-19 pandemic, which has elevated anxiety levels globally. Short-acting injectable benzodiazepines are …